PBSV
Pharma-Bio Serv, Inc.Company Information
- Company Name
- Pharma-Bio Serv, Inc.
- CIK
- CIK0001304161
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PBSV: OTC
- Fiscal Year End
- October 31
- Owner Organization
- 07 Trade & Services
- SIC
- 8742
- SIC Description
- Services-Management Consulting Services
- Ticker
- PBSV
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2021-06-25
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 234,100
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-09-14
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 2 | 6 | 3 | 4 | 2 | 7 | 7 | 7 | 4 | 6 | 10 | ||||||
Assets | ||||||||||||||||||
| Marketable Securities Current | 7 | 7 | 5 | 7 | 7 | 8 | 5 | 6 | 6 | 10 | 9 | 5 | ||||||
| Accounts Receivable Net Current | 2 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | ||||||
| Prepaid Expense And Other Assets | - | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Assets Current | 11 | 11 | 13 | 13 | 13 | 13 | 16 | 16 | 16 | 17 | 19 | 19 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 11 | 11 | 14 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 19 | 20 | ||||||
Liabilities Current | ||||||||||||||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Policyholder Dividends Payable | - | - | - | - | - | - | 2 | - | - | - | - | - | ||||||
| Dividends Payable Current | - | - | 2 | - | - | - | - | - | - | - | - | - | ||||||
| Accrued Income Taxes Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 1 | 1 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | ||||||
| Accrued Income Taxes Noncurrent | - | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Taxes Payable Current | - | - | - | 0 | - | - | - | 1 | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 1 | 1 | 3 | 2 | 2 | 2 | 4 | 3 | 3 | 3 | 5 | 4 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Additional Paid In Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Retained Earnings Accumulated Deficit | 9 | 9 | 9 | 11 | 11 | 11 | 11 | 12 | 12 | 13 | 13 | 15 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders Equity Before Treasury Stock | 11 | 11 | 11 | 12 | - | - | 13 | 14 | 14 | 14 | 15 | 17 | ||||||
| Treasury Stock Value | - | - | - | -1 | - | - | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Treasury Stock Common Value | -1 | -1 | -1 | - | -1 | -1 | - | - | - | - | - | - | ||||||
| Stockholders Equity | 10 | 10 | 10 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 14 | 16 | ||||||
| Liabilities And Stockholders Equity | 11 | 11 | 14 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 19 | 20 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | ||||||
| Shares Outstanding | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPharma-Bio Serv, Inc. (PBSV) — SEC Financial Statements & Analysis
Pharma-Bio Serv, Inc. (PBSV) is a services-management consulting services company. Pharma-Bio Serv, Inc. trades on OTC as: PBSV. Pharma-Bio Serv, Inc. (PBSV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14. Based on that filing, Pharma-Bio Serv, Inc. carries a market cap of $9.62M, a P/E ratio of 38.24x, a P/B ratio of 0.92x, a P/S ratio of 1.01x, an enterprise value of $8.10M, and an EV/EBITDA multiple of -83.50x. On profitability, it posts a gross margin of 32.32%, an operating margin of -1.63%, a net margin of 2.65%, a Return on Equity (ROE) of 2.25%, a Return on Assets (ROA) of 2.01%, and a Return on Invested Capital (ROIC) of -1.68%. Per share, it reports EPS of $0.01, diluted EPS of $0.01, free cash flow per share of $-0.02, and a dividend per share of $0.15. Over the trailing year, it posted revenue growth of 3.25% year-over-year, net income growth of -398.55% year-over-year, and EPS growth of -398.88% year-over-year. On the balance sheet, it maintains a current ratio of 11.30x, a quick ratio of 11.06x, working capital of $10.24M, a debt-to-equity ratio of 0.10x, a debt ratio of 0.09, an interest coverage ratio of 8.30x, free cash flow of $-421.36K (TTM), and net debt of $-1.52M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.62M
- P/E TTM
- 38.24x
- EPS TTM
- $0.01
- P/B TTM
- 0.92x
- ROE TTM
- 2.25%
- ROA TTM
- 2.01%
- Debt To Equity
- 0.10x
- Free Cash Flow TTM
- $-421.36K
- Net Revenue TTM Growth 1Y
- 3.25%
Data as of 2026-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pharma-Bio Serv, Inc. in?
Pharma-Bio Serv, Inc. (PBSV) operates in the Services-Management Consulting Services industry.
What exchange does PBSV trade on?
Pharma-Bio Serv, Inc. (PBSV) trades on the OTC.
When was Pharma-Bio Serv, Inc. (PBSV)'s most recent SEC filing?
Pharma-Bio Serv, Inc. (PBSV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14.
What is PBSV's market cap?
Pharma-Bio Serv, Inc. (PBSV) has a market capitalization of $9.62M as of 2026-07-31.
What is PBSV's P/E ratio?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month P/E ratio is 38.24x as of 2026-07-31.
What is PBSV's EPS (earnings per share)?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month EPS is $0.01 as of 2026-07-31.
What is PBSV's ROE (return on equity)?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month Return on Equity (ROE) is 2.25% as of 2026-07-31.
What is PBSV's ROA (return on assets)?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month Return on Assets (ROA) is 2.01% as of 2026-07-31.
What is PBSV's ROIC (return on invested capital)?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month Return on Invested Capital (ROIC) is -1.68% as of 2026-07-31.
What is PBSV's EV/EBITDA?
Pharma-Bio Serv, Inc. (PBSV)'s trailing twelve month EV/EBITDA is -83.50x as of 2026-07-31.